NCT03808103View on ClinicalTrials.gov

Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions
Crohn Disease
Interventions
BIOLOGICAL

Placebo

Orally, twice a day, for a period of fifteen days

BIOLOGICAL

Bacteriophage preparation

Orally, twice a day, for a period of fifteen days

Trial Locations (2)

10029

Icahn School of Medicine at Mount Sinai Hospital, New York

21093

Johns Hopkins Green Spring Station, Lutherville

All Listed Sponsors
collaborator

Icahn School of Medicine at Mount Sinai

OTHER

collaborator

Johns Hopkins University

OTHER

lead

Intralytix, Inc.

INDUSTRY

NCT03808103 - Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease | Biotech Hunter | Biotech Hunter